The Financial Times

The Big Read: Bayer’s €50bn blunder

Published on 13 Aug
Written by Ralph Atkins
Read by Martin Buchanan

Don't have time to finish this article? Continue from where you left off.

Playing next...

11 Oct9 minute listen

Insulin maker Novo Nordisk walks moral tightrope

The Financial Times

3 Oct3 minute listen

Max Nisen: The Market Tells Opioid Drugmakers to Settle Up


1 Oct9 minute listen

China’s pharmaceuticals industry is growing up

The Economist

16 Sept8 minute listen

Purdue Pharma, drugmaker accused of fueling the opioid epidemic, files for bankruptcy

The Washington Post

16 Sept14 minute listen

A dire scarcity of drugs is worsening, in part, because they are so cheap

The Economist

16 Sept6 minute listen

Rachel Britton: The UK is dangerously close to having a full-blown opioid crisis

The Independent

29 Aug3 minute listen

Lex: Purdue/opioids - this is going to hurt

The Financial Times

29 Aug5 minute listen

Leonid Bershidsky: Opioids Threaten to Mess Up Europe, Too


27 Aug8 minute listen

Johnson & Johnson Ordered to Pay $572 Million in Landmark Opioid Trial

The New York Times

13 Aug9 minute listen

Groundbreaking drug made from cannabis brings hope for kids with rare seizure disorders

Business Insider